Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Analyzing Major Big Pharma Players Using Relative Valuation
Seeking Alpha
Monday, October 18, 2010 - 10:07am
tags:
Abbott Laboratories, Bristol-Myers Squibb, GSK, Eli Lilly, Merck, Novartis
Qiagen Inks Deal with Abbott
Yahoo/Zacks.com
Monday, October 18, 2010 - 10:03am
tags:
Abbott Laboratories, Qiagen, HIV
Gilead Sciences Earnings Preview
TheStreet.com
Monday, October 18, 2010 - 10:00am
tags:
Gilead Sciences, earnings
Pfizer Acquires Rights to Biocon Insulin Products for $200 Million Upfront
Bloomberg
Monday, October 18, 2010 - 9:54am
tags:
M&A, Pfizer, Biocon, insulin
China Biotech Week in Review: Good News From Pfizer, Roche
Seeking Alpha
Monday, October 18, 2010 - 9:53am
tags:
China, Roche, Pfizer, MingSight, OrbusNeich, Vital Therapies
Botox Migraine Approval May Gain Allergan $1 Billion in Sales
Bloomberg
Monday, October 18, 2010 - 9:42am
tags:
FDA, migraines, Botox, Allergan
A Look at AstraZeneca Price Targets
Seeking Alpha
Monday, October 18, 2010 - 9:41am
tags:
AstraZeneca
Exelixis Deepens Profitable Ties to BMS
Seeking Alpha
Monday, October 18, 2010 - 9:41am
tags:
Bristol-Myers Squibb, Exelixis, diabetes, partnerships
Eli Lilly Scraps Late-Stage Head and Neck Cancer Drug: Biotech's Latest Tribulations
Seeking Alpha
Sunday, October 17, 2010 - 11:57am
tags:
Eli Lilly, Alimta, squamous cell cancer, head and neck cancer
GfK HealthCare Study: Physicians Ready to Accept New Oral Therapy for MS
Trading Markets
Sunday, October 17, 2010 - 11:54am
tags:
multiple sclerosis, Gilenya, Novartis
Washington Week: FDA Giveth, FDA Taketh Away
Medpagetoday.com
Sunday, October 17, 2010 - 11:34am
tags:
Botox, Menaflex, JZP-6, Girosa
Jazz Feels No Pain Following FDA Rejection
Seeking Alpha
Sunday, October 17, 2010 - 11:22am
tags:
JZP-6, fibromyalgia, Jazz Pharmaceuticals
Depomed: Long-Term Winner Holding Strong
Seeking Alpha
Sunday, October 17, 2010 - 11:20am
tags:
Depomed, Acuform
Is Johnson & Johnson a Sell?
Motley Fool
Sunday, October 17, 2010 - 11:17am
tags:
JNJ, investors
Johnson & Johnson ordered to pay $258M to La
Yahoo/AP
Sunday, October 17, 2010 - 11:16am
tags:
JNJ, Risperdal
Vivus Sells MUSE to Meda
Yahoo/Zacks
Sunday, October 17, 2010 - 11:11am
tags:
Vivus, Meda, Muse, erectile dysfunction
$3.78 Million Settlement Over SJS (Stevens Johnson Syndrome)Death of Nine-Year-Old Girl
Lawyers and Settlements
Saturday, October 16, 2010 - 10:46am
tags:
Stevens Johnson Syndrome, Dilantin, Pfizer, Flagyl, lawsuits
Early Initiation of Treatment with Copaxone (R) Provides Greater Effects in Delaying Conversion to Clinically Definite MS
Trading Markets
Saturday, October 16, 2010 - 9:41am
tags:
Copaxone, multiple sclerosis, Teva Pharmaceuticals
Dr. Reddy's announces the approval of Lansoprazole delayed-release capsules
MarketWatch
Saturday, October 16, 2010 - 9:39am
tags:
Dr Reddy's, Lansoprazole, Prevacid
Genzyme sues drug firm over wrinkle treatment
Boston Globe, MA
Saturday, October 16, 2010 - 9:18am
tags:
Genzyme, Restylane, Perlane, Medicis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.